Clinical Trial Update: [18F]HX4 PET/CT Imaging for Detection of Hypoxia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial on [18F]HX4 PET/CT imaging for detection of hypoxia in head and neck and lung cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Lung Cancer

Drugs mentioned

• [18F]HX4 PET/CT imaging (hypoxia imaging radiotracer)

Snippet

Sponsor: Nottingham University Hospitals NHS Trust | Conditions: Head and Neck Cancer, Lung Cancer | Phase 2 | Status: COMPLETED